Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
August 02, 2024
Tags
Health care industry
Eli Lilly and Co
Biotech and Pharmaceuticals
From
CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
August 01, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
July 31, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Health & Science
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Business News
Breaking News: Business
Health & Science
From
CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
July 29, 2024
Tags
Biotechnology
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
July 25, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
July 25, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Bristol/Myers Squibb Co
Health & Science
Merck & Co Inc
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
July 23, 2024
Tags
Pharmaceuticals
Health & Science
Biotech and Pharmaceuticals
From
CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
July 17, 2024
Tags
Zealand Pharma A/S
Pharmaceuticals
Business
From
CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
July 16, 2024
Tags
Pfizer Inc
Novo Nordisk A/S
Merck & Co Inc
From
CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
July 11, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
July 11, 2024
Tags
Business
Pharmaceuticals
Business News
From
CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
July 10, 2024
Tags
Stock markets
stocks
Investment Strategy
From
CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
July 10, 2024
Tags
Business
Pharmaceuticals
Sanofi SA
From
CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
July 08, 2024
Tickers
LAWS
Tags
Interest Rates
Novo Nordisk A/S
Corporate crime
From
CNBC.com News
CNBC Daily Open: French far-right advance blocked
July 07, 2024
Tags
Technology
Commercial banking
Asia Markets
From
CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
July 06, 2024
Tags
Health care costs
ETF Edge
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
July 04, 2024
Tags
Deutsche Bank AG
Health care industry
Science
From
CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
Tags
Health & Science
Altimmune Inc
Gilead Sciences Inc
From
CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
Tags
Zealand Pharma A/S
Viking Therapeutics Inc
Eli Lilly and Co
From
CNBC.com News
5 things to know before the stock market opens
June 25, 2024
Tags
Politics
NVIDIA Corp
Markets
From
CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
June 25, 2024
Tags
US Top News and Analysis
Europe: Top News And Analysis
Europe News
From
CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
June 24, 2024
Tags
Pharmaceuticals
Business
US: News
From
CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
June 21, 2024
Tags
Novo Nordisk A/S
Europe News
Markets
From
CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
June 18, 2024
Tags
Social issues
Labor economy
Novo Nordisk A/S
From
CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
June 17, 2024
Tags
Biotech and Pharmaceuticals
Novo Nordisk A/S
Eli Lilly and Co
From
CNBC.com News
European stocks set for muted open after European Central Bank cut
June 07, 2024
Tags
Novo Nordisk A/S
World Economy
Government and politics
From
CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
May 30, 2024
Tags
Health care industry
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
May 29, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.